Literature DB >> 19748838

Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry.

Diaa M Shakleya1, Marilyn A Huestis.   

Abstract

An LC-MS/MS method for the simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma was developed and fully validated. Potential endogenous and exogenous interferences were extensively evaluated and limits of quantification were determined by decreasing analyte concentration. Analytical ranges were 1-500 ng/mL for nicotine and cotinine, 5-500 ng/mL for trans-3'-hydroxycotinine and norcotinine. Mean intra- and inter-assay analytical recoveries were between 101.9 and 116.8%, and intra- and inter-assay imprecision were less than 11% RSD for all analytes: parameters were evaluated at three different concentrations across the linear range of the assay. Extraction efficiency was > or = 70% for all analytes. This validated method is useful for the determination of nicotine and metabolites in human plasma to support research on the role of nicotine biomarkers on neuronal systems mediating cognitive and affective processes and to differentiate active, passive and environmental exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748838      PMCID: PMC2763023          DOI: 10.1016/j.jchromb.2009.08.033

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  36 in total

1.  Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry.

Authors:  T Tuomi; T Johnsson; K Reijula
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

2.  Application of liquid separation techniques to the determination of the main urinary nicotine metabolites.

Authors:  K Tyrpień; T Wielkoszyński; B Janoszka; C Dobosz; D Bodzek; Z Steplewski
Journal:  J Chromatogr A       Date:  2000-02-18       Impact factor: 4.759

3.  High-performance liquid chromatographic determination of cotinine in urine in isocratic mode.

Authors:  F Ceppa; Y El Jahiri; H Mayaudon; O Dupuy; P Burnat
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-09-15

4.  Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry.

Authors:  P Jacob; S Wu; L Yu; N L Benowitz
Journal:  J Pharm Biomed Anal       Date:  2000-09       Impact factor: 3.935

5.  A simple high performance liquid chromatographic method for the quantification of total cotinine, total 3'-hydroxycotinine and caffeine in the plasma of smokers.

Authors:  O A Ghosheh; D Browne; T Rogers; J de Leon; L P Dwoskin; P A Crooks
Journal:  J Pharm Biomed Anal       Date:  2000-08-15       Impact factor: 3.935

6.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  2003-07-01       Impact factor: 6.986

7.  Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking.

Authors:  N L Benowitz; P Jacob
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

8.  Improved highly sensitive method for determination of nicotine and cotinine in human plasma by high-performance liquid chromatography.

Authors:  M Nakajima; T Yamamoto; Y Kuroiwa; T Yokoi
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-05-26

9.  Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography-mass spectrometry.

Authors:  Ho-Sang Shin; Jin-Gu Kim; Yoon-Jeong Shin; Sun Ha Jee
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-03-25       Impact factor: 3.205

10.  Simultaneous determination of the tobacco smoke uptake parameters nicotine, cotinine and thiocyanate in urine, saliva and hair, using gas chromatography-mass spectrometry for characterisation of smoking status of recently exposed subjects.

Authors:  Javier Sastre Toraño; Hendrikus J M van Kan
Journal:  Analyst       Date:  2003-07       Impact factor: 4.616

View more
  14 in total

1.  Chronic smoking, but not acute nicotine administration, modulates neural correlates of working memory.

Authors:  Matthew T Sutherland; Thomas J Ross; Diaá M Shakleya; Marilyn A Huestis; Elliot A Stein
Journal:  Psychopharmacology (Berl)       Date:  2010-09-23       Impact factor: 4.530

2.  Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers.

Authors:  Pebbles Fagan; Pallav Pokhrel; Thaddeus A Herzog; Ian S Pagano; Adrian A Franke; Mark S Clanton; Linda A Alexander; Dennis R Trinidad; Kari-Lyn K Sakuma; Carl A Johnson; Eric T Moolchan
Journal:  Nicotine Tob Res       Date:  2015-05-19       Impact factor: 4.244

3.  Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.

Authors:  Peyton Jacob; Lisa Yu; Minjiang Duan; Lita Ramos; Olivia Yturralde; Neal L Benowitz
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-21       Impact factor: 3.205

4.  Quantitation of cotinine and its metabolites in rat plasma and brain tissue by hydrophilic interaction chromatography tandem mass spectrometry (HILIC-MS/MS).

Authors:  Pei Li; Wayne D Beck; Patrick M Callahan; Alvin V Terry; Michael G Bartlett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-09-15       Impact factor: 3.205

5.  Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancer.

Authors:  Pebbles Fagan; Eric T Moolchan; Pallav Pokhrel; Thaddeus Herzog; Kevin D Cassel; Ian Pagano; Adrian A Franke; Joseph Keawe'aimoku Kaholokula; Angela Sy; Linda A Alexander; Dennis R Trinidad; Kari-Lyn Sakuma; C Anderson Johnson; Alyssa Antonio; Dorothy Jorgensen; Tania Lynch; Crissy Kawamoto; Mark S Clanton
Journal:  Am J Public Health       Date:  2015-04-16       Impact factor: 9.308

6.  Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.

Authors:  Michael J Marks; Heidi C O'Neill; Kelly M Wynalda-Camozzi; Nick C Ortiz; Emily E Simmons; Caitlin A Short; Christopher M Butt; J Michael McIntosh; Sharon R Grady
Journal:  Neuropharmacology       Date:  2015-07-17       Impact factor: 5.250

7.  A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry.

Authors:  Eleanor I Miller; Hye-Ryun K Norris; Douglas E Rollins; Stephen T Tiffany; Diana G Wilkins
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-12-22       Impact factor: 3.205

8.  Metabolic Pathways and Networks Associated With Tobacco Use in Military Personnel.

Authors:  Dean P Jones; Douglas I Walker; Karan Uppal; Patricia Rohrbeck; Col Timothy M Mallon; Young-Mi Go
Journal:  J Occup Environ Med       Date:  2016-08       Impact factor: 2.162

9.  Enhanced nicotine metabolism in HIV-1-positive smokers compared with HIV-negative smokers: simultaneous determination of nicotine and its four metabolites in their plasma using a simple and sensitive electrospray ionization liquid chromatography-tandem mass spectrometry technique.

Authors:  Ravinder Earla; Anusha Ande; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  Drug Metab Dispos       Date:  2013-12-03       Impact factor: 3.922

10.  Tobacco smoke exposure enhances reward sensitivity in male and female rats.

Authors:  Ranjithkumar Chellian; Isaac Wilks; Brandon Levin; Song Xue; Azin Behnood-Rod; Ryann Wilson; Megan McCarthy; Abhigyan Ravula; Hardik Chandasana; Hartmut Derendorf; Adriaan W Bruijnzeel
Journal:  Psychopharmacology (Berl)       Date:  2021-01-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.